Clinical trial
Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome
NCT02132195 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome
- Lead sponsor
- Emory University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- March 31, 2018
- Enrollment
- 31 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.